From Monitoring to Managing: How Digital Tools Are Changing the Diabetes Landscape

Comments · 9 Views

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, expanding at a CAGR of 8.3% from 2023 to 2030,

Digital Diabetes Management Industry Overview

 

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, expanding at a CAGR of 8.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI). 

 

Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes. 

 

Gather more insights about the market drivers, restrains and growth of the Digital Diabetes Management Market

 

The market growth is further augmented by the increasing prevalence of obesity, the growing aging population, and increasing awareness regarding diabetes preventive care. Moreover, the market is driven by the increasing number of active users of smart devices and the launch of new apps that allow patients to monitor their blood glucose. These apps use advanced technology for health care professionals and provide patients with better health outcomes. In May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India with the launch of the Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. The combination marks the entry of the next-generation BGM system. This is expected to propel the demand for the product, thereby driving the overall market in the country. 

 

 

Browse through Grand View Research's Medical Devices Industry Research Reports.

 

  • The global fixed and mobile C-arms market size was estimated at USD 3.32 billion in 2024 and is expected to expand at a CAGR of 4.2% from 2025 to 2030.

 

  • The global anti-infective agents market size was estimated at USD 135.43 billion in 2024 and is projected to grow at a CAGR of 1.61% from 2025 to 2030.

 

 

Digital Diabetes Management Market Segmentation 

 

Grand View Research has segmented the global digital diabetes management market based on product, type, end-use, and region:

 

Digital Diabetes Management Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Smart Glucose Meter
  • Continuous Blood Glucose Monitoring System
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Apps
    • Digital Diabetes Management Apps
    • Weight Diet Management Apps

 

Digital Diabetes Management Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Wearable Devices
  • Handheld Devices

 

Digital Diabetes Management End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Home settings
  • Diagnostic centers

 

Digital Diabetes Management Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE 
    • Kuwait

 

 

Key Companies profiled:

 

  • Abbott
  • Medtronic
  • Hoffmann-La Roche Ltd.
  • Bayer AG
  • Sanofi
  • Dexcom, Inc.
  • LifeScan, Inc.
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Braun Melsungen AG

 

 

Order a free sample PDF of the Digital Diabetes Management Market Intelligence Study, published by Grand View Research.

 

Comments